Bisel Hf

Controlled evaluation of adriamycin (NSC-123127) in patients with disseminated breast cancer.

Ahmann Dl, Bisel Hf, Eagan Rt et al. · PubMed · 1974 · 62 citations

Breast Oncology, Medicine, Pathology +6

Phase II clinical trial of isophosphamide (NSC-109724) in patients with advances breast cancer.

Ahmann Dl, Bisel Hf, Robert G. Hahn · PubMed · 1975 · 32 citations

Breast Oncology, Oncology, Medicine +6

Phase II evaluation of VP-16-213 (NSC-141540) and cytembena (NSC-104801) in patients with advanced breast cancer.

Ahmann Dl, Bisel Hf, Eagan Rt et al. · PubMed · 1976 · 23 citations

Tumor Biology, Advanced Breast Cancer, Phase Ii Evaluation +9

Further clinical evaluation of 2'-deoxy-5-fluorouridine (NSC-27640).

Wilson Wl, Bisel Hf, Krementz Et et al. · PubMed · 1967 · 18 citations

Therapeutic Drug Monitoring, Medicine, Clinical Pharmacology +5

Phase II study of ICRF-159 versus combination cis-dichlorodiammineplatinum(II) and DTIC in patients with disseminated malignant melanoma.

Ahmann Dl, Edmonson Jh, Stephen Frytak et al. · PubMed · 1978 · 16 citations

Malignant Disease, Medicine, Disseminated Malignant Melanoma +8